Lexicon Pharmaceuticals LXRX Convertible Preferred Stock Outstanding Shares
Convertible Preferred Stock Outstanding Shares at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesOutstanding.
The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's convertible preferred stock outstanding shares.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's convertible preferred stock outstanding shares?
- Lexicon Pharmaceuticals (LXRX) reported convertible preferred stock outstanding shares of 408.4K in Q1 2026.
- What does convertible preferred stock outstanding shares mean?
- This metric represents the total number of preferred equity shares issued by the company that possess the right to be converted into common stock at a specified ratio. It serves as a critical indicator of potential future equity dilution and the company's historical reliance on hybrid financing instruments. Investors monitor this figure to assess the impact of potential conversion events on earnings per share and overall ownership structure.